Olga Sánchez- Maroto Carrizo

I'm a graduate in Biology at the Universitat Autònoma de Barcelona. Since 2001 I have been linked to the world of clinical research in different positions. I have worked both in the public and private sphere. I have participated in different types of clinical research in various indications.

Institutions of which they are part

Cap d'Unitat
Commercial and Academic Clinical Research

Vall Hebron Institut de Recerca

Olga Sánchez- Maroto Carrizo

Institutions of which they are part

Cap d'Unitat
Commercial and Academic Clinical Research

Vall Hebron Institut de Recerca

EDUCATION
• Universitat de Barcelona, Master in Experimental Bioscience, 2001
• Universitat Autònoma de Barcelona, Bachelor in Biology. Microbiology specialist, 2000

ADDITIONAL RELEVANT TRAININGS
• Programa de Alta Dirección en Instituciones Sanitarias. IESE. 2021.
• Course on Human Rights and Bioethics in Clínics and Investigation. Universidad Nacional de Educación a Distancia. 2020
• Course on Biomedicine and Law Universidad Nacional de Educación a Distancia. 2019
• Project Management in Clinical Research. CESIF. 2018
• Basic Statisctics for Clinical Research. VHIR. March 2017
• Health and Law. Universidad Nacional de Educación a Distancia. 2008

PROFESSIONAL EXPERIENCE
Period: April 2014 – Present
Position: Unit Head Academic Research Organization
Organization: VHIR – Institut de Recerca Vall d’Hebron

Period: March 2013 – April 2014
Position: Sr. Associate Clinical Operations Manager
Organization: Amgen

Period: December 2012 – February 2013
Position: Sr. Associate Clinical Operations Manager
Organization: Pharmanet i3 (in exclusive for Amgen)

Period: January 2009 - July 2012
Position: Clinical Research Manager
Organization: RPS Research Iberica, S.L.U,

Period: September 2005 – January 2009
Position: Clinical Research Manager
Organization: Infociencia Clinical Research,

Period: November 2001 – September 2005
Position: Clinical Research Associated
Organization: Infociencia Clinical Research

Projects

LIVERHOPE: SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS

IP: -
Collaborators: Ester Palacio Gutierrez, Mª Eulàlia Molinas Guilera, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi, Joan Genescà Ferrer
Funding agency: EUROPEAN COMMISSION
Funding: 409557
Reference: LIVERHOPE_VM.VARGAS_H2020_2016
Duration: 01/01/2017 - 28/02/2023

PRESTIGE-AF: PREvention of STroke in Intracerebral hemorrhaGE survivors with Atrial Fibrillation

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla, Ariadna Martín Balcells, Olalla Pancorbo Rosal, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi, Daisy Rosalia Guaman Pilco
Funding agency: EUROPEAN COMMISSION
Funding: 481723
Reference: PRESTIGE-AF_J.MONTANER_H2020_2017
Duration: 01/12/2017 - 30/11/2024

PROOF: Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial

IP: Joan Montaner Villalonga
Collaborators: Estela Sanjuan Menendez, Anna Penalba Morenilla, Ariadna Martín Balcells, Olalla Pancorbo Rosal, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi
Funding agency: EUROPEAN COMMISSION
Funding: 715274.5
Reference: PROOF_J.MONTANER_H2020_2016
Duration: 01/01/2017 - 30/06/2023

NoCanTher: Nanomedicine Upscaling for Early Clinical Phases of Multimodal Cancer Therapy

IP: Simon Schwartz Navarro
Collaborators: Joaquin Seras Franzoso, Sandra Mancilla Zamora, Zamira Vanessa Diaz Riascos, Olga Sánchez- Maroto Carrizo, Angelica Valderrama Rodríguez
Funding agency: EUROPEAN COMMISSION
Funding: 630633.55
Reference: NOCANTHER_S.SCHWARTZ_H2020_2015
Duration: 01/04/2016 - 30/09/2021